52P HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer - Impact of single-heterozygous UGT1A1 on the clinical outcomes

Authors :: S. Yuki
K. Ito
K. Harada
Y. Kawamoto
M. Yagisawa
K. Sawada
A. Ishiguro
O. Muto
K. Hatanaka
H. Okuda
A. Sato
Y. Sasaki
M. Nakamura
T. Meguro
M. Dazai
H. Nakatsumi
A. Ueda
N. Sakamoto
Y. Sakata
Y. Komatsu
Source :: Annals of Oncology. 33:S1449
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools